Top Markets
Coin of the day
RegeneRx Biopharmaceuticals, Inc. RegeneRx Biopharmaceuticals, Inc.

RegeneRx Biopharmaceuticals, Inc.

RGRX
Rang in Aktien #42502
RegeneRx Biopharmaceuticals, Inc. is a biotechnology firm dedicated to the... RegeneRx Biopharmaceuticals, Inc. is a biotechnology firm dedicated to the advancement of therapeutic peptides, with a primary emphasis on thymosin beta 4, engineered for the protection, repair, and regeneration of tissues and organs. The company's development pipeline includes RGN-259, a preservative-free ophthalmic solution designed to restore corneal tissues following injury, disease, or other pathologies; RGN-352, an injectable formulation under investigation for its potential in treating cardiovascular ailments, central and peripheral nervous system disorders, and various other medical conditions; and RGN-137, a topical gel aimed at accelerating the healing of skin wounds and minimizing scar tissue. Strategic alliances have been forged with Lee's Pharmaceutical Group and GtreeBNT Co., Ltd. Incorporated in 1982, the company initially operated as Alpha 1 Biomedicals, Inc., adopting the name RegeneRx Biopharmaceuticals, Inc. in 2000. Its operations are headquartered in Rockville, Maryland.
Aktienkurs
$0.0007
Zuletzt synchronisiert: 2026-08-11
Marktkapitalisierung
$1.05K
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
250.00%
Land
US
Handel RegeneRx Biopharmaceuticals, Inc. (RGRX)

Kategorie

Preis RGRX mit Marktkapitalisierung von B
RegeneRx Biopharmaceuticals, Inc. RegeneRx Biopharmaceuticals, Inc.
RGRX
$0.0007
Marktkapitalisierung von RegeneRx Biopharmaceuticals, Inc.(RGRX)
Marktkapitalisierung: $1.05K
Mit Stand August 2026 hat RegeneRx Biopharmaceuticals, Inc. eine Marktkapitalisierung von $1.05K. Das macht RegeneRx Biopharmaceuticals, Inc. laut unseren Daten zum 42502nd wertvollsten Unternehmen der Welt nach Marktkapitalisierung. Die Marktkapitalisierung ist der Gesamtmarktwert aller ausstehenden Aktien eines börsennotierten Unternehmens und wird häufig verwendet, um den Unternehmenswert zu bestimmen.
Marktkapitalisierung von RegeneRx Biopharmaceuticals, Inc. von 2003 bis 2026
RGRX im Vergleich zu den Top 5 der beliebtesten stocks
Preis für RGRX Vermögenswert B Marktkapitalisierung von B Ergebnisse
RegeneRx Biopharmaceuticals, Inc. RegeneRx Biopharmaceuticals, Inc.
$3,624,231 $1.05K
$5.426T +517,747,292,835.76%
RegeneRx Biopharmaceuticals, Inc. RegeneRx Biopharmaceuticals, Inc.
$2,963,582 $1.05K
$4.437T +423,368,884,847.84%
RegeneRx Biopharmaceuticals, Inc. RegeneRx Biopharmaceuticals, Inc.
$2,770,282 $1.05K
$4.148T +395,754,553,049.84%
RegeneRx Biopharmaceuticals, Inc. RegeneRx Biopharmaceuticals, Inc.
$2,447,223 $1.05K
$3.664T +349,603,313,174.80%
RegeneRx Biopharmaceuticals, Inc. RegeneRx Biopharmaceuticals, Inc.
$1,929,843 $1.05K
$2.889T +275,691,902,872.46%